Clinical Trial: Ondansetron for the Management of Atrial Fibrillation
Study Status: Completed
Recruit Status: RECRUITING
Condition: Atrial Fibrillation
Study Type: INTERVENTIONAL
Official Title: Inhibition of Small Conductance Calcium-Activated Potassium Current: A New Therapeutic Approach for Atrial Fibrillation
Brief Summary:
"Afib" is a common irregular heartbeat.Afib can cause stroke, blood clots, dementia and death.Medicines used to treat Afib often do not work well and can cause serious side effects.Clinicians need medicines that work better for Afib.Medicines for Afib work by blocking a current in the heart called a potassium current.There is a newer potassium current called IKas that can contribute to Afib.A medicine called ondansetron is used to keep people with cancer from getting sick to their stomach and throwing…
Read more